In our study, 20% (113/555) of the breast and ovarian cancer cases were identified as carriers of PVs in associated genes, with major contributions from BRCA1 and BRCA2 genes (12% and 17%, respectively). This evidence concerns the gene BRCA2 and ovarian carcinoma.